Difference between revisions of "LncRNAWiki:S"
(Created page with "{|class="wikitable sortable" style="width:90%;text-align:center" |- !Name !Transcript ID !Alias !Description |- |''SALRNA1'' |SALRNA1 |SAL-RNA1, XLOCN/A023166 |senescence ...") |
|||
(2 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
+ | <div style="padding:0.2em 0.5em;text-align:right;font-size:125%;font-weight:bold;color:#2d2d2d;"> | ||
+ | Jump to section in alphabetical order : [[LncRNAWiki:A|'''A''']] [[LncRNAWiki:B|'''B''']] [[LncRNAWiki:C|'''C''']] [[LncRNAWiki:D|'''D''']] [[LncRNAWiki:E|'''E''']] [[LncRNAWiki:F|'''F''']] [[LncRNAWiki:G|'''G''']] [[LncRNAWiki:H|'''H''']] [[LncRNAWiki:I|'''I''']] [[LncRNAWiki:J|'''J''']] [[LncRNAWiki:K|'''K''']] [[LncRNAWiki:L|'''L''']] [[LncRNAWiki:M|'''M''']] [[LncRNAWiki:N|'''N''']] [[LncRNAWiki:O|'''O''']] [[LncRNAWiki:P|'''P''']] [[LncRNAWiki:R|'''R''']] [[LncRNAWiki:S|'''S''']] [[LncRNAWiki:T|'''T''']] [[LncRNAWiki:U|'''U''']] [[LncRNAWiki:V|'''V''']] [[LncRNAWiki:W|'''W''']] [[LncRNAWiki:X|'''X''']] [[LncRNAWiki:Y|'''Y''']] [[LncRNAWiki:Z|'''Z''']] [[LncRNAWiki:Featured|'''BACK''']] | ||
+ | </div> | ||
+ | |||
{|class="wikitable sortable" style="width:90%;text-align:center" | {|class="wikitable sortable" style="width:90%;text-align:center" | ||
|- | |- | ||
Line 5: | Line 9: | ||
!Alias | !Alias | ||
!Description | !Description | ||
+ | !Disease | ||
|- | |- | ||
|''SALRNA1'' | |''SALRNA1'' | ||
|[[SALRNA1]] | |[[SALRNA1]] | ||
− | |SAL-RNA1, XLOCN/A023166 | + | |"SAL-RNA1, XLOCN/A023166" |
|senescence associated long non-coding RNA 1 | |senescence associated long non-coding RNA 1 | ||
+ | |_ | ||
|- | |- | ||
|''SALRNA2'' | |''SALRNA2'' | ||
|[[SALRNA2]] | |[[SALRNA2]] | ||
− | |SAL-RNA2, XLOCN/A025931 | + | |"SAL-RNA2, XLOCN/A025931" |
|senescence associated long non-coding RNA 2 | |senescence associated long non-coding RNA 2 | ||
+ | |_ | ||
|- | |- | ||
|''SALRNA3'' | |''SALRNA3'' | ||
|[[SALRNA3]] | |[[SALRNA3]] | ||
− | |SAL-RNA3, XLOCN/A025918 | + | |"SAL-RNA3, XLOCN/A025918" |
|senescence associated long non-coding RNA 3 | |senescence associated long non-coding RNA 3 | ||
+ | |_ | ||
|- | |- | ||
|''SAMD12-AS1'' | |''SAMD12-AS1'' | ||
Line 25: | Line 33: | ||
|N/A | |N/A | ||
|SAMD12 antisense RNA 1 | |SAMD12 antisense RNA 1 | ||
+ | |_ | ||
|- | |- | ||
|''SAMMSON'' | |''SAMMSON'' | ||
Line 30: | Line 39: | ||
|N/A | |N/A | ||
|survival associated mitochondrial melanoma specific oncogenic non-coding RNA | |survival associated mitochondrial melanoma specific oncogenic non-coding RNA | ||
+ | |Melanoma | ||
|- | |- | ||
|''SAP30L-AS1'' | |''SAP30L-AS1'' | ||
|[[SAP30L-AS1]] | |[[SAP30L-AS1]] | ||
− | |FLJ38109, GALNT10-AS1 | + | |"FLJ38109, GALNT10-AS1" |
|SAP30L antisense RNA 1 (head to head) | |SAP30L antisense RNA 1 (head to head) | ||
+ | |_ | ||
|- | |- | ||
|''SCAANT1'' | |''SCAANT1'' | ||
Line 40: | Line 51: | ||
|SCA7/ATXN7 antisense RNA 1 | |SCA7/ATXN7 antisense RNA 1 | ||
|ATXN7-AS1 | |ATXN7-AS1 | ||
+ | |Spinocerebellar ataxia type 7 | ||
|- | |- | ||
|''SCHLAP1'' | |''SCHLAP1'' | ||
|[[NONHSAT075852]] | |[[NONHSAT075852]] | ||
|SWI/SNF complex antagonist associated with prostate cancer 1 (non-protein coding) | |SWI/SNF complex antagonist associated with prostate cancer 1 (non-protein coding) | ||
− | |SChLAP1,PCAT11 | + | |"SChLAP1,PCAT11" |
+ | |prostate cancer | ||
|- | |- | ||
|''SEC24B-AS1'' | |''SEC24B-AS1'' | ||
Line 50: | Line 63: | ||
|1/2-SBSRNA4 | |1/2-SBSRNA4 | ||
|SEC24B antisense RNA 1 | |SEC24B antisense RNA 1 | ||
+ | |_ | ||
|- | |- | ||
|''SENCR'' | |''SENCR'' | ||
Line 55: | Line 69: | ||
|smooth muscle and endothelial cell enriched migration/differentiation-associated long non-coding RNA | |smooth muscle and endothelial cell enriched migration/differentiation-associated long non-coding RNA | ||
|N/A | |N/A | ||
+ | |_ | ||
|- | |- | ||
|''SGMS1-AS1'' | |''SGMS1-AS1'' | ||
Line 60: | Line 75: | ||
|N/A | |N/A | ||
|SGMS1 antisense RNA 1 | |SGMS1 antisense RNA 1 | ||
+ | |_ | ||
|- | |- | ||
|''SHANK2-AS3'' | |''SHANK2-AS3'' | ||
Line 65: | Line 81: | ||
|N/A | |N/A | ||
|SHANK2 antisense RNA 3 | |SHANK2 antisense RNA 3 | ||
+ | |_ | ||
|- | |- | ||
|''SIRT1-AS'' | |''SIRT1-AS'' | ||
Line 70: | Line 87: | ||
|N/A | |N/A | ||
|SIRT1 antisense RNA | |SIRT1 antisense RNA | ||
+ | |Hepatocellular Carcinoma | ||
|- | |- | ||
|''SMAD1-AS1'' | |''SMAD1-AS1'' | ||
Line 75: | Line 93: | ||
|ENST00000513542 | |ENST00000513542 | ||
|SMAD1 antisense RNA 1 | |SMAD1 antisense RNA 1 | ||
+ | |Ventricular septal defects | ||
|- | |- | ||
|''SMAD5-AS1'' | |''SMAD5-AS1'' | ||
Line 80: | Line 99: | ||
|DAMS | |DAMS | ||
|SMAD5 antisense RNA 1 | |SMAD5 antisense RNA 1 | ||
+ | |_ | ||
|- | |- | ||
|''SMCR2'' | |''SMCR2'' | ||
|[[SMCR2]] | |[[SMCR2]] | ||
|N/A | |N/A | ||
− | |Smith-Magenis syndrome chromosome region, candidate 2 (non-protein coding) | + | |"Smith-Magenis syndrome chromosome region, candidate 2 (non-protein coding)" |
+ | |_ | ||
|- | |- | ||
|''SMCR5'' | |''SMCR5'' | ||
|[[SMCR5]] | |[[SMCR5]] | ||
|NCRNA00034 | |NCRNA00034 | ||
− | |Smith-Magenis syndrome chromosome region, candidate 5 (non-protein coding) | + | |"Smith-Magenis syndrome chromosome region, candidate 5 (non-protein coding)" |
+ | |_ | ||
|- | |- | ||
|''SMCR6'' | |''SMCR6'' | ||
|[[SMCR6]] | |[[SMCR6]] | ||
|N/A | |N/A | ||
− | |Smith-Magenis syndrome chromosome region, candidate 6 (non-protein coding) | + | |"Smith-Magenis syndrome chromosome region, candidate 6 (non-protein coding)" |
+ | |Smith-Magenis syndrome | ||
|- | |- | ||
|''SMG7-AS1'' | |''SMG7-AS1'' | ||
Line 100: | Line 123: | ||
|DKFZP564C196 | |DKFZP564C196 | ||
|SMG7 antisense RNA 1 | |SMG7 antisense RNA 1 | ||
+ | |_ | ||
|- | |- | ||
|''SNAI3-AS1'' | |''SNAI3-AS1'' | ||
Line 105: | Line 129: | ||
|MGC23284 | |MGC23284 | ||
|SNAI3 antisense RNA 1 | |SNAI3 antisense RNA 1 | ||
+ | |_ | ||
|- | |- | ||
|''snaR'' | |''snaR'' | ||
Line 110: | Line 135: | ||
|small NF90-associated RNAs | |small NF90-associated RNAs | ||
|small NF90-associated RNAs | |small NF90-associated RNAs | ||
+ | |_ | ||
|- | |- | ||
|''SNHG1'' | |''SNHG1'' | ||
|[[NONHSAT021826]] | |[[NONHSAT021826]] | ||
− | |UHG, ENSG00000255717 | + | |"UHG, ENSG00000255717" |
|SNHG1:Small nucleolar RNA host gene 1;UHG: U22 host gene. | |SNHG1:Small nucleolar RNA host gene 1;UHG: U22 host gene. | ||
+ | |gastric cancer | ||
|- | |- | ||
|''SNHG10'' | |''SNHG10'' | ||
|[[SNHG10]] | |[[SNHG10]] | ||
− | |FLJ40557, NCRNA00063, LINC00063 | + | |"FLJ40557, NCRNA00063, LINC00063" |
|small nucleolar RNA host gene 10 | |small nucleolar RNA host gene 10 | ||
+ | |_ | ||
|- | |- | ||
|''SNHG11'' | |''SNHG11'' | ||
Line 125: | Line 153: | ||
|LINC00101 | |LINC00101 | ||
|small nucleolar RNA host gene 11 | |small nucleolar RNA host gene 11 | ||
+ | |obesity | ||
|- | |- | ||
|''SNHG12'' | |''SNHG12'' | ||
|[[SNHG12]] | |[[SNHG12]] | ||
− | |PNAS-123, LINC00100, ASLNC04080 | + | |"PNAS-123, LINC00100, ASLNC04080" |
|small nucleolar RNA host gene 12 | |small nucleolar RNA host gene 12 | ||
+ | |osteosarcoma | ||
|- | |- | ||
|''SNHG14'' | |''SNHG14'' | ||
|[[SNHG14]] | |[[SNHG14]] | ||
− | |NCRNA00214, UBE3A-AS | + | |"NCRNA00214, UBE3A-AS" |
|small nucleolar RNA host gene 14 | |small nucleolar RNA host gene 14 | ||
+ | |Prader-Willi | ||
|- | |- | ||
|''SNHG15'' | |''SNHG15'' | ||
|[[SNHG15]] | |[[SNHG15]] | ||
− | |FLJ38860, MYO1GUT, Linc-Myo1g | + | |"FLJ38860, MYO1GUT, Linc-Myo1g" |
|small nucleolar RNA host gene 15 | |small nucleolar RNA host gene 15 | ||
+ | |hepatocellular carcinoma | ||
|- | |- | ||
|''SNHG16'' | |''SNHG16'' | ||
Line 145: | Line 177: | ||
|ncRAN | |ncRAN | ||
|small nucleolar RNA host gene 16 | |small nucleolar RNA host gene 16 | ||
+ | |bladder cancer, colorectal cancer | ||
|- | |- | ||
|''SNHG20'' | |''SNHG20'' | ||
|[[SNHG20]] | |[[SNHG20]] | ||
− | |PRO0872, FLJ25582, DKFZp686L05235, SCARNA16HG | + | |"PRO0872, FLJ25582, DKFZp686L05235, SCARNA16HG" |
|small nucleolar RNA host gene 20 | |small nucleolar RNA host gene 20 | ||
+ | |Hepatocellular Carcinoma | ||
|- | |- | ||
|''SNHG3'' | |''SNHG3'' | ||
|[[lnc-OR10H5-1:1]] | |[[lnc-OR10H5-1:1]] | ||
− | |U17HG, linc1343, ENSG00000242125 | + | |"U17HG, linc1343, ENSG00000242125" |
|Small nucleolar RNA host gene 3 | |Small nucleolar RNA host gene 3 | ||
+ | |Alzheimer's disease | ||
|- | |- | ||
|''SNHG4'' | |''SNHG4'' | ||
|[[NONHSAT104072]] | |[[NONHSAT104072]] | ||
− | |U19H, ENSG00000200959 | + | |"U19H, ENSG00000200959" |
|Small nucleolar RNA host gene 4 | |Small nucleolar RNA host gene 4 | ||
+ | |myelodysplastic syndrome | ||
|- | |- | ||
|''SNHG5'' | |''SNHG5'' | ||
|[[NONHSAT054526]] | |[[NONHSAT054526]] | ||
− | |U50HG, ENSG00000203875 | + | |"U50HG, ENSG00000203875" |
|Small nucleolar RNA host gene 5 | |Small nucleolar RNA host gene 5 | ||
+ | |lymphoma | ||
|- | |- | ||
|''SNHG6'' | |''SNHG6'' | ||
|[[lnc-TCF24-2:3]] | |[[lnc-TCF24-2:3]] | ||
− | |U87HG, ENSG00000245910 | + | |"U87HG, ENSG00000245910" |
|Small nucleolar RNA host gene 6 | |Small nucleolar RNA host gene 6 | ||
+ | |_ | ||
|- | |- | ||
|''SNHG7'' | |''SNHG7'' | ||
|[[SNHG7]] | |[[SNHG7]] | ||
− | |MGC16037, NCRNA00061 | + | |"MGC16037, NCRNA00061" |
|small nucleolar RNA host gene 7 | |small nucleolar RNA host gene 7 | ||
+ | |_ | ||
|- | |- | ||
|''SNHG8'' | |''SNHG8'' | ||
|[[SNHG8]] | |[[SNHG8]] | ||
− | |NCRNA00060, LINC00060 | + | |"NCRNA00060, LINC00060" |
|small nucleolar RNA host gene 8 | |small nucleolar RNA host gene 8 | ||
+ | |_ | ||
|- | |- | ||
|''SOCS2-AS1'' | |''SOCS2-AS1'' | ||
Line 185: | Line 225: | ||
|N/A | |N/A | ||
|SOCS2 antisense RNA 1 | |SOCS2 antisense RNA 1 | ||
+ | |_ | ||
|- | |- | ||
|''SOX21-AS1'' | |''SOX21-AS1'' | ||
Line 190: | Line 231: | ||
|N/A | |N/A | ||
|SOX21 antisense RNA 1 (head to head) | |SOX21 antisense RNA 1 (head to head) | ||
+ | |_ | ||
|- | |- | ||
|''SOX2-OT'' | |''SOX2-OT'' | ||
|[[SOX2-OT]] | |[[SOX2-OT]] | ||
− | |DKFZp761J1324, NCRNA00043 | + | |"DKFZp761J1324, NCRNA00043" |
|SOX2 overlapping transcript | |SOX2 overlapping transcript | ||
+ | |Esophageal squamous cell cancer, Alzheimer's disease,Neurodevelopmental syndromes associated with the SOX2 locus | ||
|- | |- | ||
|''SPATA3-AS1'' | |''SPATA3-AS1'' | ||
Line 200: | Line 243: | ||
|N/A | |N/A | ||
|SPATA3 antisense RNA 1 (head to head) | |SPATA3 antisense RNA 1 (head to head) | ||
+ | |_ | ||
|- | |- | ||
|''SPRY4-IT1'' | |''SPRY4-IT1'' | ||
|[[lnc-NDFIP1-3:1]] | |[[lnc-NDFIP1-3:1]] | ||
− | |AK024556, ENSG00000274721 | + | |"AK024556, ENSG00000274721" |
|SPRY4 intronic transcript 1 (non-protein coding) | |SPRY4 intronic transcript 1 (non-protein coding) | ||
+ | |melanoma | ||
|- | |- | ||
|''SRA'' | |''SRA'' | ||
|[[lnc-SRA1-1:1]] | |[[lnc-SRA1-1:1]] | ||
− | |SRA1, ENSG00000213523 | + | |"SRA1, ENSG00000213523" |
|Steroid receptor RNA Activator | |Steroid receptor RNA Activator | ||
+ | |_ | ||
|- | |- | ||
|''ST7-AS1'' | |''ST7-AS1'' | ||
Line 215: | Line 261: | ||
|ST7AS1 | |ST7AS1 | ||
|ST7 antisense RNA 1 | |ST7 antisense RNA 1 | ||
+ | |_ | ||
|- | |- | ||
|''ST7-AS2'' | |''ST7-AS2'' | ||
Line 220: | Line 267: | ||
|ST7AS2 | |ST7AS2 | ||
|ST7 antisense RNA 2 | |ST7 antisense RNA 2 | ||
+ | |_ | ||
|- | |- | ||
|''ST7OT'' | |''ST7OT'' | ||
− | |[[NONHSAT122926]],[[NONHSAT122918]],[[NONHSAT122914]],[[NONHSAT122932]] | + | |[[NONHSAT122926]],[[NONHSAT122918]], |
− | |ST7OT1, ST7OT2, ST7OT3, ST7OT4, ST7AS1, ST7AS2, ST7AS3, ST7AS4, ENSG00000214188 | + | [[NONHSAT122914]],[[NONHSAT122932]] |
+ | |"ST7OT1, ST7OT2, ST7OT3, ST7OT4, ST7AS1, ST7AS2, ST7AS3, ST7AS4, ENSG00000214188" | ||
|N/A | |N/A | ||
+ | |_ | ||
|- | |- | ||
|''ST7-OT3'' | |''ST7-OT3'' | ||
Line 230: | Line 280: | ||
|NCRNA00026 | |NCRNA00026 | ||
|ST7 overlapping transcript 3 | |ST7 overlapping transcript 3 | ||
+ | |_ | ||
|- | |- | ||
|''STAM-AS1'' | |''STAM-AS1'' | ||
Line 235: | Line 286: | ||
|locus3182 | |locus3182 | ||
|STAM antisense RNA 1 (head to head) | |STAM antisense RNA 1 (head to head) | ||
+ | |_ | ||
|- | |- | ||
|''STX18-AS1'' | |''STX18-AS1'' | ||
Line 240: | Line 292: | ||
|LOC100507266 | |LOC100507266 | ||
|STX18 antisense RNA 1 (head to head) | |STX18 antisense RNA 1 (head to head) | ||
+ | |_ | ||
+ | |- | ||
+ | |''SATB2-AS1'' | ||
+ | |[[SATB2-AS1]] | ||
+ | |N/A | ||
+ | |SATB2 antisense RNA 1 | ||
+ | |Osteosarcoma | ||
+ | |- | ||
+ | |''SKAP1-AS1'' | ||
+ | |[[SKAP1-AS1]] | ||
+ | |RP11-456D7.1 | ||
+ | |SKAP1 antisense RNA 1 | ||
+ | |pneumonia | ||
+ | |- | ||
+ | |''SLC12A5-AS1'' | ||
+ | |[[SLC12A5-AS1]] | ||
+ | |RP11-465L10.10 | ||
+ | |SLC12A5 and MMP9 antisense RNA 1 | ||
+ | |early-onset preeclampsia | ||
+ | |- | ||
+ | |''SLC16A1-AS1'' | ||
+ | |[[SLC16A1-AS1]] | ||
+ | |ENST00000421157.1 | ||
+ | |SLC16A1 antisense RNA 1 | ||
+ | |Acute myocardial infarction | ||
+ | |- | ||
+ | |''SLC25A25-AS1'' | ||
+ | |[[SLC25A25-AS1]] | ||
+ | |N/A | ||
+ | |SLC25A25 antisense RNA 1 | ||
+ | |colorectal cancer | ||
+ | |- | ||
+ | |''SLC5A4-AS1'' | ||
+ | |[[SLC5A4-AS1]] | ||
+ | |RP1-90G24.10 | ||
+ | |SLC5A4 antisense RNA 1 | ||
+ | |gastric cancer | ||
+ | |- | ||
+ | |''SLC7A11-AS1'' | ||
+ | |[[SLC7A11-AS1]] | ||
+ | |ENST00000512786 | ||
+ | |SLC7A11 antisense RNA 1 | ||
+ | |early-onset preeclampsia | ||
+ | |- | ||
+ | |''SMIM10L2B-AS1'' | ||
+ | |[[SMIM10L2B-AS1]] | ||
+ | |ENST00000453528 | ||
+ | |SMIM10L2B antisense RNA 1 | ||
+ | |early-onset preeclampsia | ||
+ | |- | ||
+ | |''SNHG18'' | ||
+ | |[[SNHG18]] | ||
+ | |N/A | ||
+ | |small nucleolar RNA host gene 18 | ||
+ | |glioma | ||
+ | |- | ||
+ | |''SNHG26'' | ||
+ | |[[SNHG26]] | ||
+ | |AC005682.5 | ||
+ | |small nucleolar RNA host gene 26 | ||
+ | |Bladder urothelial carcinoma | ||
+ | |- | ||
+ | |''SPINT1-AS1'' | ||
+ | |[[SPINT1-AS1]] | ||
+ | |RP11-532F12.5 | ||
+ | |SPINT1 antisense RNA 1 | ||
+ | |Melanoma tumorigenesis | ||
+ | |- | ||
+ | |''SPON1-AS1'' | ||
+ | |[[SPON1-AS1]] | ||
+ | |RP11-21, L19.1 | ||
+ | |SPON1 antisense RNA 1 | ||
+ | |B cell lymphoma | ||
+ | |- | ||
+ | |''STK32A-AS1'' | ||
+ | |[[STK32A-AS1]] | ||
+ | |CTC-255N20 | ||
+ | |STK32A antisense RNA 1 | ||
+ | |Osteosarcoma | ||
+ | |- | ||
+ | |''SVIL-AS1'' | ||
+ | |[[SVIL-AS1]] | ||
+ | |RP11-534G20.3 | ||
+ | |SVIL antisense RNA 1 | ||
+ | |rheumatoid arthritis | ||
+ | |- | ||
+ | |SLC9A3 antisen|- | ||
+ | |''SIX3-AS1'' | ||
+ | |[[SIX3-AS1]] | ||
+ | |SIX3OS | ||
+ | |SIX3 antisense RNA 1 | ||
+ | |_ | ||
+ | |- | ||
+ | |''SLC12A9-AS1'' | ||
+ | |[[SLC12A9-AS1]] | ||
+ | |RP11-126L15 | ||
+ | |4 | ||
+ | |SLC12A9 antisense RNA 1 | ||
+ | |- | ||
+ | |''SLC9A3-AS1'' | ||
+ | |[[SLC9A3-AS1]] | ||
+ | |UC011CLY | ||
+ | |2 | ||
+ | se RNA 1 | ||
+ | |- | ||
+ | |''SMILR'' | ||
+ | |[[SMILR]] | ||
+ | |N/A | ||
+ | |smooth muscle induced lncRNA, enhancer of proliferation | ||
+ | |_ | ||
+ | |- | ||
+ | |''SPRY4-AS1'' | ||
+ | |[[SPRY4-AS1]] | ||
+ | |THCAT68 | ||
+ | |SPRY4 antisense RNA 1 | ||
+ | |_ | ||
|} | |} |
Latest revision as of 12:41, 29 June 2017
Name | Transcript ID | Alias | Description | Disease | |
---|---|---|---|---|---|
SALRNA1 | SALRNA1 | "SAL-RNA1, XLOCN/A023166" | senescence associated long non-coding RNA 1 | _ | |
SALRNA2 | SALRNA2 | "SAL-RNA2, XLOCN/A025931" | senescence associated long non-coding RNA 2 | _ | |
SALRNA3 | SALRNA3 | "SAL-RNA3, XLOCN/A025918" | senescence associated long non-coding RNA 3 | _ | |
SAMD12-AS1 | SAMD12-AS1 | N/A | SAMD12 antisense RNA 1 | _ | |
SAMMSON | SAMMSON | N/A | survival associated mitochondrial melanoma specific oncogenic non-coding RNA | Melanoma | |
SAP30L-AS1 | SAP30L-AS1 | "FLJ38109, GALNT10-AS1" | SAP30L antisense RNA 1 (head to head) | _ | |
SCAANT1 | SCAANT1 | SCA7/ATXN7 antisense RNA 1 | ATXN7-AS1 | Spinocerebellar ataxia type 7 | |
SCHLAP1 | NONHSAT075852 | SWI/SNF complex antagonist associated with prostate cancer 1 (non-protein coding) | "SChLAP1,PCAT11" | prostate cancer | |
SEC24B-AS1 | SEC24B-AS1 | 1/2-SBSRNA4 | SEC24B antisense RNA 1 | _ | |
SENCR | ENST00000526269.2 | smooth muscle and endothelial cell enriched migration/differentiation-associated long non-coding RNA | N/A | _ | |
SGMS1-AS1 | SGMS1-AS1 | N/A | SGMS1 antisense RNA 1 | _ | |
SHANK2-AS3 | SHANK2-AS3 | N/A | SHANK2 antisense RNA 3 | _ | |
SIRT1-AS | SIRT1-AS | N/A | SIRT1 antisense RNA | Hepatocellular Carcinoma | |
SMAD1-AS1 | SMAD1-AS1 | ENST00000513542 | SMAD1 antisense RNA 1 | Ventricular septal defects | |
SMAD5-AS1 | SMAD5-AS1 | DAMS | SMAD5 antisense RNA 1 | _ | |
SMCR2 | SMCR2 | N/A | "Smith-Magenis syndrome chromosome region, candidate 2 (non-protein coding)" | _ | |
SMCR5 | SMCR5 | NCRNA00034 | "Smith-Magenis syndrome chromosome region, candidate 5 (non-protein coding)" | _ | |
SMCR6 | SMCR6 | N/A | "Smith-Magenis syndrome chromosome region, candidate 6 (non-protein coding)" | Smith-Magenis syndrome | |
SMG7-AS1 | SMG7-AS1 | DKFZP564C196 | SMG7 antisense RNA 1 | _ | |
SNAI3-AS1 | SNAI3-AS1 | MGC23284 | SNAI3 antisense RNA 1 | _ | |
snaR | lnc-BSPH1-1:1,lnc-BSPH1-2:1 | small NF90-associated RNAs | small NF90-associated RNAs | _ | |
SNHG1 | NONHSAT021826 | "UHG, ENSG00000255717" | SNHG1:Small nucleolar RNA host gene 1;UHG: U22 host gene. | gastric cancer | |
SNHG10 | SNHG10 | "FLJ40557, NCRNA00063, LINC00063" | small nucleolar RNA host gene 10 | _ | |
SNHG11 | SNHG11 | LINC00101 | small nucleolar RNA host gene 11 | obesity | |
SNHG12 | SNHG12 | "PNAS-123, LINC00100, ASLNC04080" | small nucleolar RNA host gene 12 | osteosarcoma | |
SNHG14 | SNHG14 | "NCRNA00214, UBE3A-AS" | small nucleolar RNA host gene 14 | Prader-Willi | |
SNHG15 | SNHG15 | "FLJ38860, MYO1GUT, Linc-Myo1g" | small nucleolar RNA host gene 15 | hepatocellular carcinoma | |
SNHG16 | NONHSAT056039 | ncRAN | small nucleolar RNA host gene 16 | bladder cancer, colorectal cancer | |
SNHG20 | SNHG20 | "PRO0872, FLJ25582, DKFZp686L05235, SCARNA16HG" | small nucleolar RNA host gene 20 | Hepatocellular Carcinoma | |
SNHG3 | lnc-OR10H5-1:1 | "U17HG, linc1343, ENSG00000242125" | Small nucleolar RNA host gene 3 | Alzheimer's disease | |
SNHG4 | NONHSAT104072 | "U19H, ENSG00000200959" | Small nucleolar RNA host gene 4 | myelodysplastic syndrome | |
SNHG5 | NONHSAT054526 | "U50HG, ENSG00000203875" | Small nucleolar RNA host gene 5 | lymphoma | |
SNHG6 | lnc-TCF24-2:3 | "U87HG, ENSG00000245910" | Small nucleolar RNA host gene 6 | _ | |
SNHG7 | SNHG7 | "MGC16037, NCRNA00061" | small nucleolar RNA host gene 7 | _ | |
SNHG8 | SNHG8 | "NCRNA00060, LINC00060" | small nucleolar RNA host gene 8 | _ | |
SOCS2-AS1 | SOCS2-AS1 | N/A | SOCS2 antisense RNA 1 | _ | |
SOX21-AS1 | SOX21-AS1 | N/A | SOX21 antisense RNA 1 (head to head) | _ | |
SOX2-OT | SOX2-OT | "DKFZp761J1324, NCRNA00043" | SOX2 overlapping transcript | Esophageal squamous cell cancer, Alzheimer's disease,Neurodevelopmental syndromes associated with the SOX2 locus | |
SPATA3-AS1 | SPATA3-AS1 | N/A | SPATA3 antisense RNA 1 (head to head) | _ | |
SPRY4-IT1 | lnc-NDFIP1-3:1 | "AK024556, ENSG00000274721" | SPRY4 intronic transcript 1 (non-protein coding) | melanoma | |
SRA | lnc-SRA1-1:1 | "SRA1, ENSG00000213523" | Steroid receptor RNA Activator | _ | |
ST7-AS1 | ST7-AS1 | ST7AS1 | ST7 antisense RNA 1 | _ | |
ST7-AS2 | ST7-AS2 | ST7AS2 | ST7 antisense RNA 2 | _ | |
ST7OT | NONHSAT122926,NONHSAT122918, | "ST7OT1, ST7OT2, ST7OT3, ST7OT4, ST7AS1, ST7AS2, ST7AS3, ST7AS4, ENSG00000214188" | N/A | _ | |
ST7-OT3 | ST7-OT3 | NCRNA00026 | ST7 overlapping transcript 3 | _ | |
STAM-AS1 | STAM-AS1 | locus3182 | STAM antisense RNA 1 (head to head) | _ | |
STX18-AS1 | STX18-AS1 | LOC100507266 | STX18 antisense RNA 1 (head to head) | _ | |
SATB2-AS1 | SATB2-AS1 | N/A | SATB2 antisense RNA 1 | Osteosarcoma | |
SKAP1-AS1 | SKAP1-AS1 | RP11-456D7.1 | SKAP1 antisense RNA 1 | pneumonia | |
SLC12A5-AS1 | SLC12A5-AS1 | RP11-465L10.10 | SLC12A5 and MMP9 antisense RNA 1 | early-onset preeclampsia | |
SLC16A1-AS1 | SLC16A1-AS1 | ENST00000421157.1 | SLC16A1 antisense RNA 1 | Acute myocardial infarction | |
SLC25A25-AS1 | SLC25A25-AS1 | N/A | SLC25A25 antisense RNA 1 | colorectal cancer | |
SLC5A4-AS1 | SLC5A4-AS1 | RP1-90G24.10 | SLC5A4 antisense RNA 1 | gastric cancer | |
SLC7A11-AS1 | SLC7A11-AS1 | ENST00000512786 | SLC7A11 antisense RNA 1 | early-onset preeclampsia | |
SMIM10L2B-AS1 | SMIM10L2B-AS1 | ENST00000453528 | SMIM10L2B antisense RNA 1 | early-onset preeclampsia | |
SNHG18 | SNHG18 | N/A | small nucleolar RNA host gene 18 | glioma | |
SNHG26 | SNHG26 | AC005682.5 | small nucleolar RNA host gene 26 | Bladder urothelial carcinoma | |
SPINT1-AS1 | SPINT1-AS1 | RP11-532F12.5 | SPINT1 antisense RNA 1 | Melanoma tumorigenesis | |
SPON1-AS1 | SPON1-AS1 | RP11-21, L19.1 | SPON1 antisense RNA 1 | B cell lymphoma | |
STK32A-AS1 | STK32A-AS1 | CTC-255N20 | STK32A antisense RNA 1 | Osteosarcoma | |
SVIL-AS1 | SVIL-AS1 | RP11-534G20.3 | SVIL antisense RNA 1 | rheumatoid arthritis | |
- | SIX3-AS1 | SIX3-AS1 | SIX3OS | SIX3 antisense RNA 1 | _ |
SLC12A9-AS1 | SLC12A9-AS1 | RP11-126L15 | 4 | SLC12A9 antisense RNA 1 | |
SLC9A3-AS1 | SLC9A3-AS1 | UC011CLY | 2
se RNA 1 | ||
SMILR | SMILR | N/A | smooth muscle induced lncRNA, enhancer of proliferation | _ | |
SPRY4-AS1 | SPRY4-AS1 | THCAT68 | SPRY4 antisense RNA 1 | _ |